Know Cancer

or
forgot password
  • cancer clinical trials in rochester, MN

  • Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Unspecified Childhood Solid Tumor, Protocol Specific
    Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Pancreatic Cancer
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lymphoma
    Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Colorectal Cancer
    Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Ceramide Cream in Treating Women With Cutaneous Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lung Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Unspecified Childhood Solid Tumor, Protocol Specific
    MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer
    Chemotherapy in Treating Patients With Advanced Kidney Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Kidney Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    Genetic Markers in Patients With Colorectal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Colorectal Cancer
    Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Multiple Myeloma and Plasma Cell Neoplasm
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Bladder Cancer
    Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Pancreatic Cancer, Perioperative/Postoperative Complications
    Thalidomide in Treating Patients With Myelofibrosis
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Primary Myelofibrosis
    Thalidomide in Treating Patients With Myelodysplastic Syndrome
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Ringed Sideroblasts, Secondary Myelodysplastic Syndromes
    CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Melanoma (Skin), Metastatic Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Malignant Mesothelioma
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Leukemia, Lymphoma
    Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Patients With Advanced Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    Vinorelbine in Treating Older Women With Stage IV Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Tipifarnib in Treating Young Patients With Refractory Leukemia
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Leukemia
    BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Sarcoma
    Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Endometrial Cancer
    PS-341 in Treating Patients With Metastatic Malignant Melanoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Melanoma, Stage IV Melanoma
    Screening Tests in Detecting Colorectal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Colorectal Cancer
    Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma
    Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Pancreatic Cancer
    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain Tumor, Central Nervous System Tumor
    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Prostate Cancer
    Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Neurotoxicity, Pain
    Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Hot Flashes, Prostate Cancer
    PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Refractory Multiple Myeloma, Stage III Multiple Myeloma, Unspecified Adult Solid Tumor, Protocol Specific
    Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer
    Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis
    Mayo Clinic
    Rochester, Minnesota 55905
    Primary Systemic Amyloidosis
    Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Hot Flashes
    Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Cervical Cancer, Precancerous Condition
    Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma
    Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific